This article outlines a pathway to develop the business case for One Health. It describes the origin and development of One Health and then identifies five potential areas where One Health can add value and reduce costs. These are: (1) sharing health resources between the medical and veterinary sectors; (2) controlling zoonoses in animal reservoirs; (3) early detection and response to emerging diseases; (4) prevention of pandemics; and (5) generating insights and adding value to health research and development. Examples are given for each category along with preliminary estimates of the potential savings from adopting the One Health approach. The literature reviewed suggests that one dollar invested in One Health can generate five dollars worth of benefits and a global investment of US$25 billion over 10 years could generate benefits worth at least US$125 billion. Conservation implications: the time has come to make the bigger case for massive investment in One Health in order to transform the management of neglected and emerging zoonoses and to save the lives of millions of people and hundreds of millions of animals whose production supports and nourishes billions of impoverished people per annum.

The requirement for vitamin D intake of dairy cattle has been better understood within the past few years and is well accepted by dairy producers and veterinary surgeons. In our country, as to the present author knowledge. In our country, as to the present author knowledge whether current recommendations and practices for supplemental vitamin D are meeting the needs of dairy cattle, however, is not well known. Circulatory vitamin D status of calves has been truly denoted via 25-hydroxyvitamin D [25(OH)D] metabolite levels in serum/plasma, with a concentration of 30 ng/mL proposed as a lower threshold for sufficiency. The present author was unaware of finding documented reports regarding vitamin d and its alterations among calves with respiratory distress. In the present study 16 calves (Group 1) were presenting clinical signs of respiratory problems and other 12 (Group 2) were selected as healthy control group. All necessary blood samples were taken were analyzed by Savant Fluorescent Immunoassay Device by use of Savant 25(OH)D test kits. Vitamin D (ng/mL) (X ̅ ± SE) among healthy calves and calves with pneumonia were detected as 63.21 ± 5.63 vs. 23.80 ± 2.75 with a statistical significance (p ≤0,001). In summary it should not be unwise to draw conclusion that pulmonary defence against respiratory infections should involve Vitamin D supplementation at appropriate dosages among calves.

Objective-To determine the pharmacokinetic disposition of IV administered caffeine in healthy Lama spp camelids. Animals-4 adult male alpacas and 4 adult female llamas. Procedures-Caffeine (3 mg/kg) was administered as an IV bolus. Plasma caffeine concentrations were determined by use of high-performance liquid chromatography in 6 animals and by use of liquid chromatography-mass spectrometry in 2 llamas. Results-Median elimination half-life was 11 hours (range, 9.3 to 29.8 hours) in alpacas and 16 hours (range, 5.4 to 17 hours) in llamas. The volume of distribution at steady state was 0.60 L/kg (range, 0.45 to 0.93 L/kg) in alpacas and 0.75 L/kg (range, 0.68 to 1.15 L/kg) in llamas. Total plasma clearance was 44 mL/h/kg (range, 24 to 56 mL/h/kg) in alpacas and 42 mL/h/kg (range, 30 to 109 mL/h/kg) in llamas. Conclusions and Clinical Relevance-High-performance liquid chromatography and liquid chromatography-mass spectrometry were suitable methods for determination of plasma caffeine concentrations in alpacas and llamas. Plasma caffeine concentration-time curves were best described by a 2-compartment model. Elimination half-lives, plasma clearance, volume of distribution at steady state, and mean residence time were not significantly different between alpacas and llamas. Intravenous administration of caffeine at a dose of 3 mg/kg did not induce clinical signs of excitement.

Objective-To evaluate the efficacy and safety of intra-articular administration of ethyl alcohol for arthrodesis of tarsometatarsal joints in horses. Animals-8 healthy female horses without lameness or radiographic evidence of tarsal joint osteoarthritis. Procedure-In each horse, 1 tarsometatarsal joint was treated with 4 mL of 70% ethyl alcohol and the opposite joint was treated with 4 mL of 95% ethyl alcohol. Lameness examinations were performed daily for 2 weeks, followed by monthly evaluations for the duration of the 12-month study. Radiographic evaluations of both tarsi were performed 1 month after injection and every 3 months thereafter. Gross and histologic examinations of the tarsi were undertaken at completion of the study. Results-Horses had minimal to no lameness associated with the treatments. Radiography revealed that 8 of 16 joints were fused by 4 months after treatment, with significantly more joints fused in the 70% ethyl alcohol group. Fifteen of 16 joints were considered fused at postmortem examination at 12 months. Gross and histologic examinations revealed foci of dense mature osteonal bone spanning the joint spaces. Bony fusion appeared to be concentrated on the dorsolateral, centrolateral, and plantarolateral aspects of the joints. Significant differences were not detected between treatment groups for lameness or pathologic findings. Conclusions and Clinical Relevance-Administration of ethyl alcohol into the tarsometatarsal joint of healthy horses appeared to facilitate arthrodesis of the joint in a pain-free manner. Results warrant further investigation into the potential use of ethyl alcohol in horses clinically affected with osteoarthritis of the tarsometatarsal and distal intertarsal joints.

The effect of 10 times (10x) overdose of enrofloxacin was studied in broiler chickens. One hundred and eighty chicks were classified in 3 equal groups. The first group received normal theurapeutic dose of enrofloxacin (1x) in drinking water for the first 5 consecutive days of age and repeated again at 24th -28th day of age. The second group received 10x (overdose) at the same ages. The third group was left non-medicated as a control group. Blood samples were taken on the 6th, 14th, 29th and 34th day of age for different laboratory tests. Enrofloxacin at 10x caused a decrease in the value of the following parameters: HI antibody titers to NDV vaccine at the 14th and the 34th day of age, serum albumin at the 10th day of age, hemoglobin at the 29th and the 34th day, lymphocytic count and IBDV ELISA titers at 29th day of age, uric acid at 29th day, phagocytic activity at 34th day, Lactobacillus spp. count in duodenum, feed conversion efficiency and body weight gain. The 10x (overdose) increased serum urea and creatinine at 29th day of age, serum AST and ALT at 29th and 34th day of age, and heterophilic count. Histopathological degeneration in liver, spleen, kidneys, bursa of Fabricius and thymus were demonstrated by 10x (overdose) of enrofloxacin. Challenge with vNDV caused 66.6% mortality in birds received the 10x (overdose) compared with 33.3% in the vaccinated non treated control group.

A retrospective study was employed to investigate the effect of dry period length on reproduction, incidence of reproductive and metabolic disorders and milk production in Holstein cows belonging to a commercial dairy. Over a 5 year period (2000- 2005), data about reproductive performance, postpartum and metabolic disorders were collected on 1914 multiparous Holstein cows. Out of the obtained data production performance were available only for 793 cows. According to the obtained data the dry period was categorized into 10 groups of different lengths. Reproductive performances including the interval to 1st service, service period, number of inseminations per conception, day’s open, calving interval and percentage of pregnant cows within 100 days in milking (DIM) were recorded as a function of dry period length. The incidence of postpartum reproductive and metabolic disorders included retained fetal membranes (RFM), endometritis, cystic ovarian disease (COD), mastitis, milk fever (MF), ketosis and abomasal displacement were recorded as a function of dry period length. Milk production was also studied in relation to dry period length. Statistical analysis of the obtained data was performed. The most important notifiable results were: cows with dry period less than 28 days showed the best reproductive performance and the highest incidence of abomasal displacement among all groups. In general, the incidence of MF and RFM were higher in short dry period cows, while the incidence of ketosis was higher in cows with long dry period length. A highly significant difference was recorded between daily milk yield of cows with dry period less than 64 days (27.23 kg) and those of cows with dry period > 64 days (25.20 kg). Finally, it is recommended to keep the dry period of 40-60 day lengths to obtain optimum reproduction, health and production of Holstein cows.

Objective-To evaluate the effect of dietary supplementation with the probiotic strain Lactobacillus acidophilus DSM13241 in healthy adult cats. Animals-15 adult cats. Procedures-Cats were fed a nutritionally complete dry food for 5 weeks. Fecal character was assessed daily, and a single fecal sample and 3-mL blood sample were collected for bacterial enumeration and hematologic analysis, respectively. Cats were then fed the same diet supplemented with L acidophilus DSM13241 (2 X 10(8) CFU/d) for 4.5 weeks. Repeat fecal and hematologic measurements were taken prior to the return to control diet for a 4-week period. Results-The probiotic species was recovered from feces, demonstrating survival through the feline gastrointestinal tract. Probiotic supplementation was associated with increased numbers of beneficial Lactobacillus and L acidophilus groups in feces and decreased numbers of Clostridium spp and Enterococcus faecalis, indicating an altered bacterial balance in the gastrointestinal tract microflora. Fecal pH was also decreased suggesting a colonic environment selective for the beneficial lactic acid bacterial population. Systemic and immunomodulatory effects were associated with administration of L acidophilus DSM13241 including altered cell numbers within WBC subsets and enhanced phagocytic capacity in the peripheral granulocyte population. In addition, plasma endotoxin concentrations were decreased during probiotic feeding, and RBCs had a decreased susceptibility to osmotic pressure. Conclusions and Clinical Relevance-Probiotic strain L acidophilus DSM13241 fed at 2 X 10(8) CFU/d can alter the balance of gastrointestinal microflora in healthy cats. Furthermore, administration of this probiotic results in beneficial systemic and immunomodulatory effects in cats.

Objective-To determine the disposition of a bolus of meloxicam (administered IV) in horses and donkeys (Equus asinus) and compare the relative pharmacokinetic variables between the species. Animals-5 clinically normal horses and 5 clinically normal donkeys. Procedures-Blood samples were collected before and after IV administration of a bolus of meloxicam (0.6 mg/kg). Serum meloxicam concentrations were determined in triplicate via high-performance liquid chromatography. The serum concentration-time curve for each horse and donkey was analyzed separately to estimate standard noncompartmental pharmacokinetic variables. Results-In horses and donkeys, mean +/- SD area under the curve was 18.8 +/- 7.31 microgram/mL/h and 4.6 +/- 2.55 microgram/mL/h, respectively; mean residence time (MRT) was 9.6 +/- 9.24 hours and 0.6 +/- 0.36 hours, respectively. Total body clearance (CL(T)) was 34.7 +/- 9.21 mL/kg/h in horses and 187.9 +/- 147.26 mL/kg/h in donkeys. Volume of distribution at steady state (VD(SS)) was 270 +/- 160.5 mL/kg in horses and 93.2 +/- 33.74 mL/kg in donkeys. All values, except VD(SS), were significantly different between donkeys and horses. Conclusions and Clinical Relevance-The small VD(SS) of meloxicam in horses and donkeys (attributed to high protein binding) was similar to values determined for other nonsteroidal anti-inflammatory drugs. Compared with other species, horses had a much shorter MRT and greater CL(T) for meloxicam, indicating a rapid elimination of the drug from plasma; the even shorter MRT and greater CL(T) of meloxicam in donkeys, compared with horses, may make the use of the drug in this species impractical.

Objective: The objective of the current study was to investigate the influence of probiotic Chrysonilia crassa in comparison with zinc bacitracin, commercial probiotic Bacillus subtilis, and herbal medicine waste on growth, intestinal microbiology, and blood indices of broilers. Materials and methods: Three hundreds of Lohmann day-old chicks were allocated to control diet (basal diet; CONT), basal diet with antibiotic zinc bacitracin (AZB), basal diet with B. subtilis (PROB), basal diet with C. crassa (PROC), and basal diet with herbal medicine waste (HERBW). Sample collections were conducted on day 34 of the experiment. Results: PROB showed greater (P [J Adv Vet Anim Res 2018; 5(3.000): 332-342]

Objective: This study investigated the effects of dietary piperine (PIP) supplementation on feed efficiency, growth performance, digestive enzyme activity, hemolymph biochemistry, antioxidant and immune responses, and disease resistance in whiteleg shrimp (Litopenaeus vannamei) chal¬lenged with Vibrio parahemolyticus. Materials and Methods: A total of 320 shrimps (4.38 gm ± 0.2 gm) were randomly distributed into four treatments and fed a basal diet or supplemented with 0, 0.5 (PIP0.5), 1 (PIP1.0), and 2 (PIP2) gm/kg of diet. Results: The dietary inclusion of PIP significantly improved growth performance, blood proteins, and efficiency, resulting in the best results in the PIP2 group. Diets containing PIP led to significant improvements in crude protein and lipid content while also significantly reducing moisture con¬tent in a quadratic-dependent manner (p < 0.05). Shrimp in the PIP1 and PIP2 groups exhibited higher total protein and albumin levels compared to the free-PIP and PIP0.5 groups (p < 0.05). Shrimp-fed PIP-enriched diets showed lower lipid profiles (total cholesterol, triglycerides, and low-density lipoprotein) and liver enzymes (gam¬ma-glutamyl transferase and lactate dehydrogenase) in a quadratic trend (p < 0.05) compared to the control diet. Shrimp-fed diets containing PIPs exhibited a significant quadratic increase in digestive enzyme activity compared to those without PIPs (p < 0.05). The inclusion of PIP in the diet significantly enhanced antioxidant enzymes and reduced malondialdehyde levels, as well as the inflammatory response (Interleukin 4, Interferon-gamma, and LYZ) in shrimp. Conclusion: These findings suggest that dietary PIP supplementation holds promise as a feed additive for enhancing growth, immunity, and disease resistance in whiteleg shrimp. [J Adv Vet Anim Res 2024; 11(4.000): 996-1006]